TEVA-TECH Trademark

Trademark Overview


On Friday, January 24, 2003, a trademark application was filed for TEVA-TECH with the United States Patent and Trademark Office. The USPTO has given the TEVA-TECH trademark a serial number of 78206879. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2012. This trademark is owned by TEVA Pharmaceutical Industries Ltd.. The TEVA-TECH trademark is filed in the Chemical Products category with the following description:

chemical intermediates and active chemical ingredients for use in pharmaceuticals
teva-tech

General Information


Serial Number78206879
Word MarkTEVA-TECH
Filing DateFriday, January 24, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 28, 2012
Registration Number3022869
Registration DateTuesday, December 6, 2005
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 13, 2005

Trademark Statements


Indication of Colors claimedThe color(s) shades of green is/are claimed as a feature of the mark.
Description of the Colors ClaimedThe mark consists of the words TEVA-TECH in dark green and a circle to the left of these words that consists of three different shades of green.
Goods and Serviceschemical intermediates and active chemical ingredients for use in pharmaceuticals
Pseudo MarkTEVA TECH
Translation of Words in MarkThe English translation of "TEVA" is "nature".

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 28, 2012
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA Pharmaceutical Industries Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Party NameTEVA Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Party NameTEVA Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events


Event DateEvent Description
Friday, September 28, 2012CANCELLED SEC. 8 (6-YR)
Wednesday, December 1, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 1, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 5, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 5, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 10, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 10, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 6, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, September 13, 2005PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2005NOTICE OF PUBLICATION
Monday, May 23, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 25, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 23, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, March 7, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 7, 2005PAPER RECEIVED
Saturday, January 8, 2005AMENDMENT FROM APPLICANT ENTERED
Monday, December 27, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 8, 2005ASSIGNED TO LIE
Monday, December 27, 2004PAPER RECEIVED
Wednesday, June 23, 2004NON-FINAL ACTION MAILED
Monday, May 17, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 17, 2004PAPER RECEIVED
Friday, February 27, 2004LETTER OF SUSPENSION MAILED
Monday, December 15, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 15, 2003PAPER RECEIVED
Thursday, July 24, 2003NON-FINAL ACTION MAILED
Tuesday, July 8, 2003ASSIGNED TO EXAMINER
Monday, March 24, 2003PAPER RECEIVED